Minerva Surgical Inc
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally… Read more
Minerva Surgical Inc (UTRS) - Total Assets
Latest total assets as of September 2023: $72.78 Million USD
Based on the latest financial reports, Minerva Surgical Inc (UTRS) holds total assets worth $72.78 Million USD as of September 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Minerva Surgical Inc - Total Assets Trend (2019–2022)
This chart illustrates how Minerva Surgical Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Minerva Surgical Inc - Asset Composition Analysis
Current Asset Composition (December 2022)
Minerva Surgical Inc's total assets of $72.78 Million consist of 52.4% current assets and 47.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 10.1% |
| Accounts Receivable | $7.24 Million | 10.5% |
| Inventory | $16.85 Million | 24.5% |
| Property, Plant & Equipment | $5.31 Million | 7.7% |
| Intangible Assets | $26.78 Million | 38.9% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2022)
This chart illustrates how Minerva Surgical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Minerva Surgical Inc's current assets represent 52.4% of total assets in 2022, a decrease from 93.9% in 2019.
- Cash Position: Cash and equivalents constituted 10.1% of total assets in 2022, down from 58.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 38.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 38.9% of total assets.
Minerva Surgical Inc Competitors by Total Assets
Key competitors of Minerva Surgical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Minerva Surgical Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Minerva Surgical Inc generates 0.73x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Minerva Surgical Inc is currently not profitable relative to its asset base.
Minerva Surgical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.88 | 2.14 | 1.37 |
| Quick Ratio | 1.03 | 1.40 | 1.06 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $18.75 Million | $ 26.20 Million | $ 12.15 Million |
Minerva Surgical Inc - Advanced Valuation Insights
This section examines the relationship between Minerva Surgical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -40.1% |
| Total Assets | $68.90 Million |
| Market Capitalization | $276.91 USD |
Valuation Analysis
Below Book Valuation: The market values Minerva Surgical Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Minerva Surgical Inc's assets decreased by 40.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Minerva Surgical Inc (2019–2022)
The table below shows the annual total assets of Minerva Surgical Inc from 2019 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $68.90 Million | -40.13% |
| 2021-12-31 | $115.09 Million | +25.04% |
| 2020-12-31 | $92.05 Million | +97.17% |
| 2019-12-31 | $46.68 Million | -- |